Dynamics of Plasma Refill Rate and Intradialytic Hypotension during Hemodialysis: Retrospective Cohort Study with Causal Methodology
Background: Attaining the optimal balance between achieving adequate volume removal while preserving organ perfusion is a challenge for patients receiving maintenance hemodialysis. Current strategies to guide ultrafiltration are inadequate.
Methods: We developed an approach to calculate plasma refill rate throughout hemodialysis using hematocrit and ultrafiltration data in a retrospective cohort of patients receiving maintenance hemodialysis at 17 dialysis units from January 2017-October 2019. We studied whether (1) plasma refill rate is associated with traditional risk factors for hemodynamic instability using logistic regression, (2) low starting plasma refill rate is associated with intradialytic hypotension using Cox proportional hazard regression, and (3) time-varying plasma refill rate throughout hemodialysis is associated with hypotension using marginal structural modeling.
Results: During 180,319 hemodialysis sessions among 2554 patients, plasma refill rate had high within- and between-patient variability. Female sex and hypoalbuminemia were associated with low plasma refill rate at multiple time points during the first hour of hemodialysis. Low starting plasma refill rate had higher hazards of intradialytic hypotension while high starting plasma refill rate was protective (HR 1.26, 95% CI 1.18, 1.35 versus HR 0.79, 95% CI 0.73, 0.85, respectively). However, when accounting for time-varying plasma refill rate and time-varying confounders, compared to a moderate plasma refill rate, while a consistently low plasma refill rate was associated with increased risk of hypotension (OR 1.09, 95% CI 1.02, 1.16), a consistently high plasma refill rate had a stronger association with hypotension within the next 15 minutes (OR 1.38, 95% CI 1.30, 1.45).
Conclusions: We present a straightforward technique to quantify plasma refill that could easily integrate with devices that monitor hematocrit during hemodialysis. Our study highlights how examining patterns of plasma refill may enhance our understanding of circulatory changes during hemodialysis, an important step to understanding how current technology might be utilized to improve hemodynamic instability.
Copyright © 2023 by the American Society of Nephrology.
No abstract available.
Abstract Introduction: Several factors affect the survival of End Stage Kidney Disease (ESKD) patients on dialysis. Machine learning (ML) models may help tackle multivariable and complex, often non-linear predictors of adverse clinical events in ESKD patients. In this study, we used advanced ML method as well as a traditional statistical method to develop and compare the...
Abstract In patients with kidney failure treated by hemodialysis, intradialytic arterial oxygen saturation (SaO2) time series present intermittent high-frequency high-amplitude oximetry patterns (IHHOP), which correlate with observed sleep-associated breathing disturbances. A new method for identifying such intermittent patterns is proposed. The method is based on the analysis of recurrence in the time series through the...
Abstract Oxidative stress (OS) is essential in uremia-associated comorbidities, including renal anemia. Complications experienced by hemodialysis (HD) patients, such as hypoxemia and uremic toxins accumulation, induce OS and premature death of red blood cells (RBC). We aimed to characterize reactive oxygen species (ROS) production and antioxidant pathways in HD-RBC and RBC from healthy controls (CON-RBC)...
Abstract Objectives: Despite the possibility of concurrent infection with COVID-19 and malaria, little is known about the clinical course of coinfected patients. We analysed the clinical outcomes of patients with concurrent COVID-19 and malaria infection. Methods: We conducted a retrospective cohort study that assessed prospectively collected data of all patients who were admitted between May and December...
Abstract For the treatment of postmenopausal osteoporosis, several drug classes with different mechanisms of action are available. Since only a limited set of dosing regimens and drug combinations can be tested in clinical trials, it is currently unclear whether common medication strategies achieve optimal bone mineral density gains or are outperformed by alternative dosing schemes...